Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

88.9%

+2.3% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 1
2(50.0%)
4Total
Phase 3(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06430671Phase 1Completed

Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Role: collaborator

NCT05391841Withdrawn

Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee

Role: lead

NCT04186208Active Not Recruiting

Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients

Role: lead

NCT03319797Phase 3Completed

NOVOCART® Inject Plus for Cartilage Defects of the Knee

Role: lead

NCT01656902Phase 3Completed

Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects

Role: lead

NCT01640457Phase 1Completed

Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine

Role: lead

NCT03808623Completed

Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC

Role: lead

NCT02179346Completed

Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects

Role: lead

NCT02348697Completed

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects

Role: lead

NCT02941120Completed

Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects

Role: lead

All 10 trials loaded